Every 10-Q that Brown-Forman Corporation (BF) has filed with the SEC in the last 24 months is listed below, newest first, and each one links through to the document itself with the summary and the scores our analysis gives it.
A 10-Q covers the quarterly report filed between annual reports, so if you follow BF and want that one kind of document rather than the whole filing history, this is the page to keep. The company's other filings, of every form, are on the full BF filings page.
Brown-Forman Corporation (BF) reported slightly lower first-quarter fiscal 2027 net sales of $911 million, down 1% from $924 million a year earlier, as unfavorable price/mix and the end of the Korbel relationship offset higher volumes, positive foreign exchange, and ready-to-drink growth. Gross profit declined 1% to $549 million, but gross margin improved to 60.2% from 59.8%, helped by lower costs and exiting Korbel, partly offset by FX and mix. Operating income fell 3% to $252 million, and operating margin edged down to 27.7% from 28.2% due to higher SG&A despite lower advertising and the absence of restructuring charges.
Net income increased to $176 million from $170 million, and diluted EPS rose 6% to $0.38, driven mainly by sharply lower non-operating postretirement expense and the prior year’s share repurchases. Operating cash flow improved to $173 million from $160 million on stronger earnings and lower working capital needs. Brown-Forman repaid the €300 million 1.20% notes that matured in July 2026 and raised commercial paper borrowings to $359 million, while maintaining total assets around $7.8 billion and total equity near $4.0 billion. Management reports no material legal, liquidity, or control issues and has completed its previously announced restructuring initiative.
Brown-Forman Corporation reports softer results for the six months ended October 31, 2025, as a tough macro environment and portfolio changes weighed on performance. Net sales were $1.96 billion, down 4% from $2.05 billion, with declines in the United States and developed markets partly offset by growth in emerging markets and Travel Retail. Gross profit fell 4% to $1.17 billion, though gross margin inched up to 59.5% as divestitures and mix slightly improved profitability.
Operating income declined 9% to $565 million, pressured by restructuring charges, the absence of a prior-year franchise tax refund, and foreign exchange. Diluted earnings per share decreased 13% to $0.83 from $0.96, reflecting lower operating income and higher non‑operating postretirement expense. Cash from operations improved sharply to $292 million from $129 million, helped by working capital, while the company continued dividends and repurchased treasury stock.
Brown-Forman reported mixed first-quarter fiscal 2026 results with modest declines in top-line and profitability while pursuing cost realignment. Net sales were $924 million, down 3% year-over-year, driven by the Sonoma-Cutrer divestiture, foreign exchange headwinds, and lower used-barrel sales, partially offset by higher volumes and distributor inventory builds. Gross profit totaled $552 million (down 2%) and gross margin improved to 59.8% from 59.4%. Operating income was $260 million, down 7%, reflecting foreign exchange, the absence of a prior-year franchise tax refund, restructuring costs, and lower gross profit. Diluted EPS was $0.36, down 13% year-over-year. The company recognized $60 million of restructuring and other charges to date and expects $60–$70 million in aggregate. Cash and cash equivalents were $471 million at July 31, 2025 (about 54% held overseas). Management reiterated fiscal 2026 outlook: organic net sales and organic operating income declines in the low-single-digit range; effective tax rate ~21%–23%; and capital expenditures of $125–$135 million.